Despite the promising market growth, regulatory compliance and stringent guidelines continue to pose challenges for MDI ...

Federal Circuit Ruling Potentially Upends Orange Book Patent Listing Requirements, Expert Analysis Reveals This ruling marks a pivotal moment in Hatch-Waxman practice, potentially altering how ...

Xopenex HFA (levalbuterol) In 2011, Primatene Mist was pulled from the market due to its use of chlorofluorocarbons (CFCs) as a propellant, which was banned for environmental reasons. After ...

Medically reviewed by Daniel More, MD Medications that target inflammation, such as immunotherapy and steroids, treat allergic asthma, a common type of asthma. Identifying triggers and avoiding ...

The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange Book tees up a pharmaceutical-industry push for the Supreme Court to weigh in ...

A chronic dry cough is a common symptom of asthma. Inhaled corticosteroids, quick-relief inhalers, and oral medications may help ease asthma symptoms, including a cough. Some alternative ...

Six individuals were evacuated from the premises before SCDF arrived. Two were assessed for smoke inhalation and declined to be sent to the hospital. SCDF added that an unmanned firefighting ...

2024 ordering Teva Pharmaceuticals (“Teva”) to delist certain patents related to Teva’s ProAir® HFA metered-dose inhaler from the FDA’s Orange Book, and that the Federal Circuit ...

It also lowers the risk of an asthma attack. Airsupra comes as an aerosol that you inhale through your mouth via the Airsupra inhaler. Airsupra contains the active ingredients albuterol and ...

Teva Pharmaceutical Industries Ltd. failed to convince the Federal Circuit to reconsider a December ruling that five patents related to its ProAir HFA asthma inhaler must be delisted from the FDA’s ...

In October 2023, Teva Pharmaceuticals filed a patent infringement lawsuit against Amneal Pharmaceuticals alleging that their generic version of Teva’s ProAir® HFA inhaler infringed upon the ...